TRAVERE THERAPEUTICS, INC. (TVTX)
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stantec delivers strong second quarter 2026 results, expands margins and raises adjusted EBITDA outlook for 2026
MariMed Reports Second Quarter 2026 Earnings
NowVertical Group Announces Second Quarter 2026 Earnings Release Date and Financial Update Webinar
Carpenter Technology Declares Quarterly Cash Dividend
The Cheesecake Factory Named to the ‘PEOPLE Companies That Care’ List for Sixth Consecutive Year
Mexco Energy Corporation Reports Financial Results for First Quarter
Ken Giacobbe Joins Carpenter Technology’s Board of Directors
Virtuix Reschedules First Quarter Fiscal 2027 Results Following Recent Transition to New Independent Accounting Firm
Epsilon Announces Second Quarter 2026 Results and 2026 Production and Capital Guidance